Related references
Note: Only part of the references are listed.Perampanel in 12 patients with Unverricht-Lundborg disease
Arielle Crespel et al.
EPILEPSIA (2017)
Behavioural changes in patients with intellectual disability treated with perampanel
E. Andres et al.
ACTA NEUROLOGICA SCANDINAVICA (2017)
Efficacy and tolerability of perampanel in ten patients with Lafora disease
Danielle Goldsmith et al.
EPILEPSY & BEHAVIOR (2016)
Add-on perampanel in Lance-Adams syndrome
Bernhard J. Steinhoff et al.
EPILEPSY & BEHAVIOR CASE REPORTS (2016)
Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy A randomized trial
Jacqueline A. French et al.
NEUROLOGY (2015)
Use of perampanel in one case of super-refractory hypoxic myoclonic status: Case report
Estevo Santamarina et al.
EPILEPSY & BEHAVIOR CASE REPORTS (2015)
A multicenter survey of clinical experiences with perampanel in real life in Germany and Austria
Bernhard J. Steinhoff et al.
EPILEPSY RESEARCH (2014)
Seizure control and improvement of neurological dysfunction in Lafora disease with perampanel
Maya Dirani et al.
EPILEPSY & BEHAVIOR CASE REPORTS (2014)
Perampanel, a selective, noncompetitive aleph-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: Interim results from phase III, extension study 307
Gregory L. Krauss et al.
EPILEPSIA (2013)
Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: A pooled analysis of three phase III studies
Bernhard J. Steinhoff et al.
EPILEPSIA (2013)
Sustained seizure remission on perampanel in progressive myoclonic epilepsy (Lafora disease)
Kathrin Schorlemmer et al.
EPILEPSY & BEHAVIOR CASE REPORTS (2013)
Adjunctive perampanel for refractory partial-onset seizures Randomized phase III study 304
Jacqueline A. French et al.
NEUROLOGY (2012)
Randomized phase III study 306 Adjunctive perampanel for refractory partial-onset seizures
G. L. Krauss et al.
NEUROLOGY (2012)
Perampanel: A novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy
Takahisa Hanada et al.
EPILEPSIA (2011)
Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures
S. Noachtar et al.
NEUROLOGY (2008)
Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy
S. F. Berkovic et al.
NEUROLOGY (2007)
Topiramate or valproate in patients with juvenile myoclonic epilepsy: A randomized open-label comparison
Paul M. Levisohn et al.
EPILEPSY & BEHAVIOR (2007)
Share Paper
